Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Usability Evaluation of the Intelligent Fingerprinting Drug Screening System

NCT: NCT07758777 · COMPLETED

NCT IDNCT07758777
StatusCOMPLETED
Start Date2026-07-20
Completion2026-07-24
SponsorIntelligent Bio Solutions Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective performance evaluation of usability of the Intelligent Fingerprinting Drug Screening System, conducted in clinic. The total number of healthy adult subjects (male and female) required for enrollment in this study protocol is 45: 15 operators and 30 donors (ideally two donors assigned to one operator). The total duration of the study, from check-in through the end of the study will be 2-4 hours for each donor subject.

Frequently Asked Questions

What is Usability Evaluation of the Intelligent Fingerprinting Drug Screening System?

Usability Evaluation of the Intelligent Fingerprinting Drug Screening System is a clinical trial registered under NCT07758777. Current status: COMPLETED.

What is the status of NCT07758777?

The current status of NCT07758777 (Usability Evaluation of the Intelligent Fingerprinting Drug Screening System) is: COMPLETED.

When did Usability Evaluation of the Intelligent Fingerprinting Drug Screening System start?

Usability Evaluation of the Intelligent Fingerprinting Drug Screening System started on 2026-07-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.